GAROFALO ELIZABETH A.
SEC insider (Form 3/4/5 filer). CIK 0001826361. Director at Alector, Inc. (ALEC) and 2 other issuers. 15 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in SAN DIEGO, CA.
Companies GAROFALO ELIZABETH A. has filed insider reports for
- Alector, Inc. (ALEC): Director
- Xenon Pharmaceuticals Inc. (XENE): Director
- ACADIA PHARMACEUTICALS INC (ACAD): Director
GAROFALO ELIZABETH A.
CIK: 0001826361
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Jun 17, 2026ALEC
Alector, Inc.
AwardDirect28.7K shares- - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
10.5K shares- - Jun 3, 2026XENE
Xenon Pharmaceuticals Inc.
AwardDirectRestricted Share Units
1.6K shares- - Jun 1, 2026XENE
Xenon Pharmaceuticals Inc.
ExerciseDirect2.6K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectDirector Stock Options (Right to Buy)
16K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect8.1K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
AwardDirectRestricted Stock Units
9.3K shares- - Sep 2, 2025ACAD
ACADIA PHARMACEUTICALS INC
SaleDirect1.6K shares at avg. $25.98$42K - Jun 11, 2025ALEC
Alector, Inc.
AwardDirect28.7K shares- - Jun 5, 2025XENE
Xenon Pharmaceuticals Inc.
AwardDirectShare Option (Right to Buy)
17K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 | ALEC Alector, Inc. | Award | 28,700 | - | $0 | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 10,507 | - | - | Direct |
| Jun 3, 2026 | XENE Xenon Pharmaceuticals Inc. | Award Restricted Share Units | 1,593 | - | - | Direct |
| Jun 1, 2026 | XENE Xenon Pharmaceuticals Inc. | Exercise | 2,645 | - | $0 | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Director Stock Options (Right to Buy) | 16,004 | - | - | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Exercise | 8,107 | - | $0 | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award Restricted Stock Units | 9,311 | - | - | Direct |
| Sep 2, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Sale | 1,600 | $25.98 | $41,560 | Direct |
| Jun 11, 2025 | ALEC Alector, Inc. | Award | 28,700 | - | - | Direct |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | Award Share Option (Right to Buy) | 17,012 | - | - | Direct |
1-10 of 15 transactions